Is fibrinogen concentrate useful for bleeding in high-risk cardiac surgery? In a study conducted in The Netherlands, [1] 647 patients (from 2011 to 2015) scheduled to have high-risk cardiac surgery ...
PARAMUS, N.J.--(BUSINESS WIRE)--Octapharma USA will present multiple clinical research posters focused on the efficacy and safety of fibryga ®, Fibrinogen (Human) Lyophilized Powder for Reconstitution ...
HOBOKEN, N.J. (November 5, 2019) - Octapharma USA sponsored a scientific symposium, "Fibrinogen Supplementation in Surgical Patients - New Perspectives in Acquired Fibrinogen Deficiency," at the ...
American Red Cross Declares Nation’s First-Ever National Blood Crisis with COVID-19 Continuing to Overwhelm Hospitals PARAMUS, N.J.--(BUSINESS WIRE)--Patient blood management strategies have become ...
In the AdFIrst study, Biotest's fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired fibrinogen deficiency (AFD) as equivalent to standard ...
EQS-News: Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate 14.02.2024 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS ...
image: The U.S. Food and Drug Administration (FDA) has approved two Octapharma supplements to Biological License Applications, strengthening the company's pediatric critical care product portfolio.
A new guide offers recommendations for the nonsurgical management of major hemorrhage, which is a challenging clinical problem. Major hemorrhage is a significant cause of death and can occur in a ...
One of the primary fibrinogen concentrate market trends driving demand is the improved detection of congenital and acquired bleeding disorders. Enhanced diagnostic protocols, including genetic testing ...
Image by Zherebetskyy - Using Vesta visualisation software plotted the developed model similar to the Science paper, CC BY-SA 3.0 Image by Zherebetskyy - Using Vesta visualisation software plotted the ...
The human fibrinogen concentrate market is on a steady growth propelled by several pivotal factors. There is rise in global incidence of bleeding disorders necessitating the utilization of human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results